Since we were able to show a positive effect of HPSE2 treatment on renal function in experimental models for glomerular diseases, our data strongly adds to the current body of literature on the promise of HPSE2 as a therapeutic in glomerular diseases. This evidence concerns the gene HPSE2 and glomerular disorder.